Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
Expert Opinion on Pharmacotherapy|June 7, 2011
Expert opinion on current therapies for nonalcoholic fatty liver diseaseClaudia Della Corte, Anna Alisi, Raffaele Iorio, et al.
Vaccine|May 21, 2011
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girlClaudia Della Corte, Antonio Carlucci, Paola Francalanci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 3, 2024
β-Klotho as novel therapeutic target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A narrative reviewMarica Meroni, Paola Dongiovanni, Francesca Tiano, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 25, 2005
Thyroid status affects rat liver regeneration after partial hepatectomy by regulating cell cycle and apoptosisAnna Alisi, Ilaria Demori, Silvana Spagnuolo, et al.
International Journal of Molecular Sciences|November 22, 2013
ADAR enzyme and miRNA story: a nucleotide that can make the differenceSara Tomaselli, Barbara Bonamassa, Anna Alisi, et al.
World Journal of Gastroenterology|November 12, 2014
MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseNadia Panera, Daniela Gnani, Annalisa Crudele, et al.
The Journal of Pediatrics|March 11, 2014
Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese childrenStefano Cianfarani, Elena Inzaghi, Anna Alisi, et al.
Pageof 21